about
Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian RegistryContractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial.Real-time 3-dimensional transthoracic echocardiography improves the diagnosis of isolated ventricular noncompaction.[Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm AssociImpact of mitral regurgitation on the outcome of patients treated with CRT-D: data from the InSync ICD Italian Registry.Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trialP wave assessment: state of the art update.Impact of acute changes of left ventricular contractility on the transvalvular impedance: validation study by pressure-volume loop analysis in healthy pigsAtrial septal pacing: a new approach to prevent atrial fibrillation.Sample size estimates for atrial fibrillation endpoints.Critical appraisal of cardiac implantable electronic devices: complications and managementRationale and design of the health economics evaluation registry for remote follow-up: TARIFFDigital technology in cardiac pacing: methods for morphology analysis of sensed endocavitary signals.Physiologic pacing: new modalities and pacing sites.Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: a post hoc analysis of the Clinical Evaluation on Advanced Resynchronization (CLEAR) pilot study.Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry.HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.Cardiac amyloidosis: the heart of the matter.Usefulness of continuous electrocardiographic monitoring for atrial fibrillation.Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations.Hemodynamic sensor in cardiac implantable electric devices: the endocardial accelaration technology.Left atrial appendage closure: a new technique for clinical practice.Automatic optimization of cardiac resynchronization therapy using SonR-rationale and design of the clinical trial of the SonRtip lead and automatic AV-VV optimization algorithm in the paradym RF SonR CRT-D (RESPOND CRT) trial.Management of atrial fibrillation in bradyarrhythmias.The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.Cardiac Resynchronization Therapy: An Overview on Guidelines.ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training.Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial.Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation.Hemodynamics of His Bundle pacing.The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?The effects of gender on electrical therapies for the heart: procedural considerations, results and complications: A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC).Economic analysis of remote monitoring of cardiac implantable electronic devices: Results of the Health Economics Evaluation Registry for Remote Follow-up (TARIFF) study.Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapy.Simultaneous His Bundle and Left Ventricular Pacing for Optimal Cardiac Resynchronization Therapy Delivery: Acute Hemodynamic Assessment by Pressure-Volume Loops.Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.
P50
Q30594176-CCF05CF5-5B57-4391-B96A-5AA2B26DE2B2Q30842053-BC320225-02A2-4E32-ACCB-3A8229BA4A5BQ33154936-6531B216-CE85-4CAE-8527-365804DF4C35Q33159767-48C0F992-A424-4F15-8F45-7D51E725879EQ33162947-0B132E19-BB87-4AB0-9096-B3E4CA40EA4BQ34088474-4402BE81-0F4F-4288-8E75-58231DD5AB8AQ34175991-CD70A1E5-45D4-48A3-A0A1-32B0F42BA42EQ34626361-30C9F3CD-6A57-4B28-B539-471F7D879849Q34736036-1622AA40-334F-4588-8122-4988CE4DC332Q35049142-8B991A7B-FBB4-4297-A049-CCB7A41D3CABQ35800257-69A2476A-251D-4838-9C12-BC6D8A323131Q36105990-4DA6A20F-A8AB-4353-B157-FD72A7904581Q36160503-2BB4D452-8293-4071-93CF-FEAA8AE11DC3Q36351829-EA3417E2-AD6A-4FF0-B404-E0E3ADD60FBBQ36363815-C03D2C0A-021C-42C6-8E90-D1F9FEA7F549Q36684064-419321A1-2311-47AD-8950-E768D83235F0Q37032387-06B25B27-B864-4C97-8167-3B6254E99DD9Q37222357-08C61D4A-2CB8-4F15-98AC-2CB64678707BQ37343853-B74F96C9-6BB0-423B-A350-A6B62159A7B8Q37753192-BBC894FD-72DD-4D54-AFD8-C49371236E22Q37776977-0E00ABAF-46DF-4BF5-8E5F-C89274F2BED9Q37899075-2F03FEF6-71FC-429A-9475-784268034D25Q38002640-F981D125-F75B-465C-875D-148782A53A8CQ38003238-656D818D-82A9-4AFB-9EE8-792CC87D774BQ38167242-4791F1C2-0660-4668-9130-F01D2DE821C1Q38167586-A35CD9F4-27FF-4995-AAC6-044C30A2B9B2Q38198194-32DD02CB-55F6-4135-AEC1-690B08DAAACAQ38381414-419C112E-82B1-4BA0-99B7-6711041F97E5Q38383016-FF4DE666-B02F-472C-B895-E2957AAAD714Q38644121-AFBD1C32-D9FE-4C74-A5FE-BD277C09711FQ38656357-77581397-9E0A-44F6-A075-8CDF3152EFA2Q38784883-87FB5AE6-AB98-432B-BE53-D10B7B04A1B0Q39045143-C0ABFE05-FEF1-4139-8147-574A99BB4E62Q39064004-43B31EAE-6997-4CDF-A41F-E680FED626C2Q39067494-5FBE5C15-F749-4C82-9C27-5E61B2E60A4AQ39315683-7420C2E7-C24B-42D1-B1DB-E2DDF10B4358Q39404437-65CD8EC7-85D8-4475-8F9F-F083134FE2EAQ39604641-905FABD8-8312-4889-837A-0C123A50598CQ39780651-B0DA8C48-C05E-4B1F-BDD5-539FE7564E08Q40258511-C7AC0185-18B7-416A-BD34-99AC57FCC844
P50
name
Luigi Padeletti
@en
type
label
Luigi Padeletti
@en
prefLabel
Luigi Padeletti
@en